Local Institution - 251

Paris 75010

0 studies enrolling now · 1 studies all time

What they study most

Leukemia, Myeloid, Acute, Myelodysplastic Syndromes

Studies at this site

• An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML) — Completed